MGB Wealth Management LLC Lowers Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

MGB Wealth Management LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 29.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 2,793 shares of the healthcare conglomerate’s stock after selling 1,157 shares during the quarter. MGB Wealth Management LLC’s holdings in UnitedHealth Group were worth $1,418,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of UNH. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group in the fourth quarter worth approximately $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $37,000. Friedenthal Financial bought a new position in UnitedHealth Group in the 3rd quarter worth $51,000. Highline Wealth Partners LLC purchased a new position in shares of UnitedHealth Group in the third quarter worth $55,000. Finally, Legacy Investment Solutions LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at approximately $57,000. 87.86% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

UNH has been the subject of several analyst reports. Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a report on Friday, January 10th. UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Stephens upped their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Finally, Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Down 1.2 %

Shares of UnitedHealth Group stock opened at $527.31 on Thursday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The business has a fifty day simple moving average of $526.25 and a 200-day simple moving average of $563.96. The firm has a market cap of $485.27 billion, a price-to-earnings ratio of 34.02, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter in the previous year, the company posted $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Transactions at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction dated Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.